Eltrombopag
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Heart, Lung, and Blood Institute (NHLBI)
Overview
Eltrombopag is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Eltrombopag clinical trials
Explore related
Medical disclaimer. This page summarizes research about Eltrombopag for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.